Clinical Trial Update: Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

An open-label early-phase study in Parkinson's disease assessing brain alpha-synuclein deposition via PET using the radiotracer [18F]MK-0947; the trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F]MK-0947 (MK-0947)

Snippet

Sponsor: Invicro | Conditions: Parkinson's Disease (PD), Parkinson's Disease | EARLY_Phase 1 | Status: RECRUITING